BofA maintains Buy on BioNTech, price target at $150

Nov 4, 2024 · On Monday, BofA Securities maintained its positive outlook on BioNTech (NASDAQ: BNTX), with a reiterated Buy rating and a $150.00 price target. The decision …

$150
OFF

BofA Maintains Buy On BioNTech, Price Target At $150

2 weeks from now

Nov 4, 2024 · On Monday, BofA Securities maintained its positive outlook on BioNTech (NASDAQ: BNTX), with a reiterated Buy rating and a $150.00 price target. The decision …

investing.com

$150.00
OFF

Bank Of America Securities Keeps Their Buy Rating On BioNTech SE …

2 weeks from now

21 hours ago · Bank of America Securities analyst Tazeen Ahmad maintained a Buy rating on BioNTech SE (BNTX – Research Report) yesterday and set a price target of $150.00. The …

businessinsider.com

$25
OFF

BioNTech Price Target Raised By $25 At BofA, Here’s Why

2 weeks from now

Sep 16, 2024 · BofA raised the firm’s price target on BioNTech to $150 from $125 and keeps a Buy rating on the shares after the company presented several updates from the oncology …

investingchannel.com

$150
OFF

BofA Maintains Buy On BioNTech, Price Target At $150

2 weeks from now

Nov 4, 2024 · BofA maintains Buy on BioNTech, price target at $150. Open in App ...

investing.com

$125.00
OFF

BioNTech's (BNTX) Buy Rating Reaffirmed At HC Wainwright

2 weeks from now

Nov 18, 2024 · Bank of America lifted their price target on BioNTech from $125.00 to $150.00 and gave the company a "buy" rating in a research report on Monday, September 16th. TD Cowen …

marketbeat.com

$150
OFF

BioNTech Stock Target Raised On Promising Drug Data

2 weeks from now

Sep 16, 2024 · BofA Securities increased its price target for BioNTech (NASDAQ: BNTX) shares to $150 from $125, while maintaining a Buy rating. The adjustment follows BioNTech's …

investing.com

49%
OFF

BioNTech (BNTX) Stock Forecast And Price Target 2025 - MarketBeat

2 weeks from now

5 days ago · According to the 17 analysts' twelve-month price targets for BioNTech, the average price target is $142.72. ... $96.00 $150.00 +21.49%: 9/16/2024: Bank of America Subscribe to …

marketbeat.com

$121.33
OFF

Forecasting The Future: 15 Analyst Projections For BioNTech

2 weeks from now

Oct 7, 2024 · Analysts have set 12-month price targets for BioNTech, revealing an average target of $121.33, a high estimate of $150.00, and a low estimate of $85.00.

nasdaq.com

$125.00
OFF

BioNTech Target Of Unusually High Options Trading …

2 weeks from now

Jan 8, 2025 · Bank of America lifted their price objective on shares of BioNTech from $125.00 to $150.00 and gave the stock a “buy” rating in a research report on Monday, September 16th.

etfdailynews.com

$126.94
OFF

Breaking Down BioNTech: 16 Analysts Share Their Views

2 weeks from now

Nov 6, 2024 · Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $126.94, with a high estimate of $150.00 and a low estimate of $91.00.

nasdaq.com

$239
OFF

BioNTech Stock Gets Upgrade, Analyst Sees Multiple Upside …

2 weeks from now

BofA Securities has upgraded BioNTech SE (NASDAQ: BNTX) and maintains a $239 price target. The analyst views the current valuation as an attractive entry opportunity citing several near …

yahoo.com

$150
OFF

BofA Maintains Buy On BioNTech, Price Target At $150

2 weeks from now

Nov 4, 2024 · BofA maintains Buy on BioNTech, price target at $150. Open in App ...

investing.com

$172
OFF

BioNTech Positioned For Solid Growth Amid Oncology Transition: …

2 weeks from now

5 days ago · Truist initiated with a Buy rating and a price target of $172. BioNTech’s oncology pipeline was previously seen as limited in value outside BNT316. ... Maintains. Buy. Feb 2022. …

yahoo.com

$150
OFF

Jefferies Upgrades BioNTech Stock On Promising Cancer Drug …

2 weeks from now

Sep 17, 2024 · BofA Securities increased its price target for BioNTech to $150 from $125, following updates from its oncology pipeline at the European Society for Medical Oncology …

investing.com

$140.76
OFF

Brokerages Set BioNTech SE (NASDAQ:BNTX) Price Target At $140.76

2 weeks from now

Dec 25, 2024 · Deutsche Bank Aktiengesellschaft lifted their price target on BioNTech from $95.00 to $150.00 and gave the stock a “buy” rating in a research note on Thursday, …

etfdailynews.com

62%
OFF

BofA Securities Upgrades BioNTech (BNTX) To Buy Amid …

2 weeks from now

Dec 15, 2022 · Price: $142.06 -1.62% Rating Summary: ... (Updated - December 15, 2022 9:22 AM EST) BofA Securities analyst ... "We upgrade BioNTech (BNTX) to Buy and maintain our …

streetinsider.com

$125
OFF

B Of A Securities Maintains Buy On BioNTech, Raises Price Target …

2 weeks from now

Sep 16, 2024 · B of A Securities analyst Tazeen Ahmad maintains BioNTech (NASDAQ:BNTX) with a Buy and raises the price target from $125 to $150.

sahmcapital.com

FAQs about BofA maintains Buy on BioNTech, price target at $150 Coupon?

Should you buy biontech se (bntx – research report)?

In a report released today, Tazeen Ahmad from Bank of America Securities reiterated a Buy rating on BioNTech SE (BNTX – Research Report), with a price target of $150.00. ...

Is biontech a good stock to buy?

Deutsche Bank Aktiengesellschaft lifted their price target on BioNTech from $95.00 to $150.00 and gave the stock a “buy” rating in a research note on Thursday, September 19th. Finally, UBS Group increased their price objective on BioNTech from $97.00 to $131.00 and gave the company a “neutral” rating in a research note on Wednesday, September 18th. ...

What is the target price for biontech se?

Goldman Sachs Adjusts Price Target on BioNTech SE to $156 From $177, Maintains Neutral Rat.. Morgan Stanley Raises Price Target on BioNTech to $216 From $203, Maintains Equal-Weight R.. ...

What is the average price target for biontech (bntx)?

According to the 14 analysts' twelve-month price targets for BioNTech, the average price target is $135.54. The highest price target for BNTX is $171.00, while the lowest price target for BNTX is $100.00. The average price target represents a forecasted upside of 22.24% from the current price of $110.88. ...

Should you buy biontech se (AHM)?

According to TipRanks, Ahmad has an average return of 0.8% and a 47.97% success rate on recommended stocks. Currently, the analyst consensus on BioNTech SE is a Strong Buy with an average price target of $143.99, implying a 28.07% upside from current levels. ...

How do I receive news & ratings for biontech?

Receive News & Ratings for BioNTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioNTech and related companies with MarketBeat.com's FREE daily email newsletter. He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. ...